Heparin does not improve myocardial glucose metabolism suppression in [18 F]FDG PET/CT in patients with low β-hydroxybutyrate level
Abstract Background Inadequate myocardial glucose metabolism suppression (GMS) can hamper interpretation of cardiac [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET/CT). Use of β-hydroxybutyrate (BHB) measurement before [18F]FDG injection has been proposed for predicting adequate GMS....
| 出版年: | EJNMMI Research |
|---|---|
| 主要な著者: | Suvi Hartikainen, Ville Vepsäläinen, Tiina Laitinen, Marja Hedman, Tomi Laitinen, Tuomo Tompuri |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
SpringerOpen
2024-10-01
|
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s13550-024-01153-y |
類似資料
Cardiometabolic disorders affect myocardial [18F]fluorodeoxyglucose uptake– impact on diagnostic PET/CT imaging
著者:: Suvi Hartikainen, 等
出版事項: (2025-07-01)
著者:: Suvi Hartikainen, 等
出版事項: (2025-07-01)
Neuroregeneration Improved by Sodium-D,L-Beta-Hydroxybutyrate in Primary Neuronal Cultures
著者:: Csilla Ari, 等
出版事項: (2024-08-01)
著者:: Csilla Ari, 等
出版事項: (2024-08-01)
Beta-hydroxybutyrate (BHB) elicits concentration-dependent anti-inflammatory effects on microglial cells which are reversible by blocking its monocarboxylate (MCT) importer
著者:: Chase Garcia, 等
出版事項: (2025-07-01)
著者:: Chase Garcia, 等
出版事項: (2025-07-01)
An open-label, acute clinical trial in adults to assess ketone levels, gastrointestinal tolerability, and sleepiness following consumption of (R)-1,3-butanediol (Avela™)
著者:: James Lowder, 等
出版事項: (2023-06-01)
著者:: James Lowder, 等
出版事項: (2023-06-01)
Text mining datasets of β-hydroxybutyrate (BHB) supplement products’ consumer online reviews
著者:: Ji Li, 等
出版事項: (2020-06-01)
著者:: Ji Li, 等
出版事項: (2020-06-01)
Stress increases blood beta‐hydroxybutyrate levels and prefrontal cortex NLRP3 activity jointly in a rodent model
著者:: Tsuyoshi Nishiguchi, 等
出版事項: (2021-06-01)
著者:: Tsuyoshi Nishiguchi, 等
出版事項: (2021-06-01)
A systematic review and meta-regression of exogenous ketone infusion rates and resulting ketosis—A tool for clinicians and researchers
著者:: Kristi L. Storoschuk, 等
出版事項: (2023-06-01)
著者:: Kristi L. Storoschuk, 等
出版事項: (2023-06-01)
Ketogenic diets and β-hydroxybutyrate in the prevention and treatment of diabetic kidney disease: current progress and future perspectives
著者:: Junle Li, 等
出版事項: (2025-03-01)
著者:: Junle Li, 等
出版事項: (2025-03-01)
Beta-Hydroxybutyric Acid as a Template for the X-ray Powder Diffraction Analysis of Gamma-Hydroxybutyric Acid
著者:: Domenica Marabello, 等
出版事項: (2024-10-01)
著者:: Domenica Marabello, 等
出版事項: (2024-10-01)
Exposure to β-hydroxybutyrate reduces the operating set point and increases excitability in hippocampal circuitry of healthy mice
著者:: Thais Tessari Zampieri, 等
出版事項: (2025-10-01)
著者:: Thais Tessari Zampieri, 等
出版事項: (2025-10-01)
A randomized, open-label, parallel pilot study investigating metabolic product kinetics of the novel ketone ester, bis-hexanoyl (R)-1,3-butanediol, over one week of ingestion in healthy adults
著者:: Eunice Mah, 等
出版事項: (2023-06-01)
著者:: Eunice Mah, 等
出版事項: (2023-06-01)
FDG-PET AND PET/CT - Part I
著者:: Amol M Takalkar, 等
出版事項: (2007-07-01)
著者:: Amol M Takalkar, 等
出版事項: (2007-07-01)
Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders
著者:: Naomi Elyse Omori, 等
出版事項: (2023-04-01)
著者:: Naomi Elyse Omori, 等
出版事項: (2023-04-01)
18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
著者:: Leila Allahqoli, 等
出版事項: (2023-10-01)
著者:: Leila Allahqoli, 等
出版事項: (2023-10-01)
Recent Updates of PET in Lymphoma: FDG and Beyond
著者:: Sung-Yong Kim, 等
出版事項: (2024-10-01)
著者:: Sung-Yong Kim, 等
出版事項: (2024-10-01)
UTILIDAD DEL PET-FDG EN PATOLOGÍA NEUROPEDIATRICA
著者:: Teresa Massardo V, 等
出版事項: (2007-01-01)
著者:: Teresa Massardo V, 等
出版事項: (2007-01-01)
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study
著者:: Virginia Pérez-Grijalba, 等
出版事項: (2019-12-01)
著者:: Virginia Pérez-Grijalba, 等
出版事項: (2019-12-01)
Subclinical Ketosis in Dairy Herds: Impact of Early Diagnosis and Treatment
著者:: Giuseppe Cascone, 等
出版事項: (2022-06-01)
著者:: Giuseppe Cascone, 等
出版事項: (2022-06-01)
The role of 18F-FDG PET/CT in the management of large-vessel vasculitis: applications and limitations in clinical practice
著者:: Maria V. Mattoli, 等
出版事項: (2012-01-01)
著者:: Maria V. Mattoli, 等
出版事項: (2012-01-01)
Impact of Renal Failure on F18-FDG PET/CT Scans
著者:: Vishwajit Kode, 等
出版事項: (2017-07-01)
著者:: Vishwajit Kode, 等
出版事項: (2017-07-01)
FDG PET/CT and thyroid biopsy leads to neurosarcoidosis diagnosis
著者:: Catherine Bullock, MD, 等
出版事項: (2023-11-01)
著者:: Catherine Bullock, MD, 等
出版事項: (2023-11-01)
The Association between Blood Β-Hydroxybutyric Acid Concentration in the Second Week of Lactation and Reproduction Performance of Lithuanian Black and White Cows
著者:: Indrė Mečionytė, 等
出版事項: (2022-02-01)
著者:: Indrė Mečionytė, 等
出版事項: (2022-02-01)
FDG-PET in mantle cell lymphoma involving skin
著者:: Mehmet Sönmez, 等
出版事項: (2010-12-01)
著者:: Mehmet Sönmez, 等
出版事項: (2010-12-01)
FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
著者:: Anna Rubinski, 等
出版事項: (2020-10-01)
著者:: Anna Rubinski, 等
出版事項: (2020-10-01)
Optimizing oral 3-hydroxybutyrate dosage using pharmacokinetic model to improve cognitive function and mood in healthy subjects
著者:: Kentaro Nishioka, 等
出版事項: (2025-01-01)
著者:: Kentaro Nishioka, 等
出版事項: (2025-01-01)
The Impact of FDG-PET for the Preoperative Management of Patients with Colorectal Cancer
著者:: Zafer Kılbaş, 等
出版事項: (2011-06-01)
著者:: Zafer Kılbaş, 等
出版事項: (2011-06-01)
18F-FDG PET/CT findings of erythema induratum
著者:: KyungAh Chun, MD, PhD
出版事項: (2025-04-01)
著者:: KyungAh Chun, MD, PhD
出版事項: (2025-04-01)
Comparing the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in breast cancer recurrence: a systematic review and meta-analysis
著者:: Shiqing Liu, 等
出版事項: (2025-08-01)
著者:: Shiqing Liu, 等
出版事項: (2025-08-01)
MRI VS. FDG-PET for diagnosis of response to neoadjuvant therapy in patients with locally advanced rectal cancer
著者:: Peng Fei Gao, 等
出版事項: (2023-01-01)
著者:: Peng Fei Gao, 等
出版事項: (2023-01-01)
Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI
著者:: Christian Martin Meerwein, 等
出版事項: (2015-02-01)
著者:: Christian Martin Meerwein, 等
出版事項: (2015-02-01)
Denosumab-Induced Osteonecrosis of the Jaw with FDG PET/CT imaging features.
著者:: SALONI RAJKOTIA, 等
出版事項: (2024-11-01)
著者:: SALONI RAJKOTIA, 等
出版事項: (2024-11-01)
Evaluation of the efficiency of FDG PET/CT in detection and characterization of skeletal metastases
著者:: Ahmed Wafaie, 等
出版事項: (2014-03-01)
著者:: Ahmed Wafaie, 等
出版事項: (2014-03-01)
FDG and Non-FDG Radiopharmaceuticals for PET Imaging in Invasive Lobular Breast Carcinoma
著者:: Laura Gilardi, 等
出版事項: (2023-05-01)
著者:: Laura Gilardi, 等
出版事項: (2023-05-01)
Comparing the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI for detecting bone metastases in breast cancer: a meta-analysis
著者:: Xia Longjie, 等
出版事項: (2023-07-01)
著者:: Xia Longjie, 等
出版事項: (2023-07-01)
Assessing large language models for Lugano classification of malignant lymphoma in Japanese FDG-PET reports
著者:: Rintaro Ito, 等
出版事項: (2025-03-01)
著者:: Rintaro Ito, 等
出版事項: (2025-03-01)
[18F]FDG uptake of the normal spinal cord in PET/MR imaging: comparison with PET/CT imaging
著者:: Marco Aiello, 等
出版事項: (2020-08-01)
著者:: Marco Aiello, 等
出版事項: (2020-08-01)
What is the utility of blood beta-hydroxybutyrate measurements in emergency department in patients without diabetes: a systematic review
著者:: Su An Hui, 等
出版事項: (2023-04-01)
著者:: Su An Hui, 等
出版事項: (2023-04-01)
FDG PET/CT Imaging of sarcomatoid hepatocellular carcinoma: A case report
著者:: Zhiyan Chen, 等
出版事項: (2024-08-01)
著者:: Zhiyan Chen, 等
出版事項: (2024-08-01)
Atypical Muscular Sarcoidosis Involvement Revealed by 18F-FDG PET/CT
著者:: Yousif A. Lucinian, 等
出版事項: (2022-12-01)
著者:: Yousif A. Lucinian, 等
出版事項: (2022-12-01)
A Marked FDG Uptake on PET/CT Corresponding to Low-Grade Ductal Carcinoma In Situ of the Breast
著者:: Viktor Michanov Jensen, 等
出版事項: (2025-09-01)
著者:: Viktor Michanov Jensen, 等
出版事項: (2025-09-01)
類似資料
-
Cardiometabolic disorders affect myocardial [18F]fluorodeoxyglucose uptake– impact on diagnostic PET/CT imaging
著者:: Suvi Hartikainen, 等
出版事項: (2025-07-01) -
Neuroregeneration Improved by Sodium-D,L-Beta-Hydroxybutyrate in Primary Neuronal Cultures
著者:: Csilla Ari, 等
出版事項: (2024-08-01) -
Beta-hydroxybutyrate (BHB) elicits concentration-dependent anti-inflammatory effects on microglial cells which are reversible by blocking its monocarboxylate (MCT) importer
著者:: Chase Garcia, 等
出版事項: (2025-07-01) -
An open-label, acute clinical trial in adults to assess ketone levels, gastrointestinal tolerability, and sleepiness following consumption of (R)-1,3-butanediol (Avela™)
著者:: James Lowder, 等
出版事項: (2023-06-01) -
Text mining datasets of β-hydroxybutyrate (BHB) supplement products’ consumer online reviews
著者:: Ji Li, 等
出版事項: (2020-06-01)
